NAFDAC builds capacity of patent medicines dealers on identification of substandard, unregistered medicines
NAFDAC builds capacity of patent medicines dealers on identification of substandard, unregistered medicines The National Agency for Food, Drug Administration and Control (NAFDAC) has built capacity of patent and proprietary medicines dealers on identification, avoidance and reporting suspicious substandard and unregistered medicine and medicine-related products. The Director, South-East Zone of NAFDAC,Continue Reading
















